Organogenesis Holdings Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ORGO Nasdaq 2836 organogenesis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Organogenesis Holdings Inc.

Organogenesis (ORGO) Q2 2026 Earnings Call Transcript - Aug 13th, 2026 5:46 pm
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution - Aug 9th, 2026 11:10 pm
Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed? - Aug 8th, 2026 2:12 am
Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary - Aug 7th, 2026 6:30 am
Organogenesis Q2 Earnings Call Highlights - Aug 7th, 2026 1:04 am
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 2:05 pm
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - Jul 27th, 2026 2:05 pm
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - Jul 9th, 2026 5:30 am
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis - Jul 6th, 2026 2:05 pm
Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update - May 20th, 2026 2:43 pm
Spotlight On Penny Stocks To Consider In May 2026 - May 14th, 2026 12:05 pm
Undervalued Small Caps With Insider Buying To Watch In May 2026 - May 14th, 2026 5:39 am
Organogenesis (ORGO) Q1 2026 Earnings Transcript - May 8th, 2026 11:28 am
Organogenesis Holdings Inc. Q1 2026 Earnings Call Summary - May 8th, 2026 6:30 am
Organogenesis Q1 Earnings Call Highlights - May 8th, 2026 6:07 am
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results - May 7th, 2026 2:05 pm
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® - Apr 28th, 2026 2:30 pm
Undiscovered Gems In The US Market Featuring 3 Promising Stocks - Apr 15th, 2026 11:33 am